|
|
Article: Promise of Multiple Benefits Underlines the Growing Popularity of Lab-on-chip and Microfluidics, Says Frost & Sullivan.
- Article from:
- Blood Weekly
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Microfluidics and lab-on-chip is a field with tremendous growth potential. As it is primarily an enabling technology, coupled with the fact that this is an era of miniaturisation, which has already swept up the information and communications industry, the life sciences industry has come to realise its potential. Microelectronics provides striking opportunities for advancing biomedical research and creating new markets for the medical sciences industry (see also Pharmaceuticals).
New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com/), European Lab-on-chip and Microfluidics Market, finds that the market earned revenues of about $666.3 million in ...